C. Legrand

发表

Neutrophil:Lymphocyte Ratio and Intraoperative Use of Ketorolac or Diclofenac are Prognostic Factors in Different Cohorts of Patients Undergoing Breast, Lung, and Kidney Cancer Surgery

J. Machiels, B. Tombal, P. Forget, 2013, Annals of Surgical Oncology.

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Y Wang, Mike Clarke, Donald A. Berry, 2005, The Lancet.

A randomized placebo-controlled study of intravenous montelukast for the treatment of acute asthma.

R. Chapela, L. Fabbri, C. Camargo, 2010, The Journal of allergy and clinical immunology.

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Ivanov, Harris, R. Collins, 2005, The Lancet.

Short-term treatment-related symptoms and quality of life: results from an international randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an EORTC Lung-Cancer Group and National Cancer Institute, Canada, Intergroup Study.

G. Giaccone, A. Bottomley, J. V. van Meerbeeck, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Morbidity and mortality in the surgery arm of EORTC 08941 trial

G. Giaccone, P. V. Van Schil, J. V. van Meerbeeck, 2005, European Respiratory Journal.

A randomized trial of radical surgery (S) versus thoracic radiotherapy (TRT) in patients (pts) with stage IIIA-N2 non-small cell lung cancer (NSCLC) after response to induction chemotherapy (ICT) (EORTC 08941)

G. Giaccone, E. Smit, F. Schramel, 2005 .

Soluble Mesothelin, Megakaryocyte Potentiating Factor, and Osteopontin as Markers of Patient Response and Outcome in Mesothelioma

K. Nackaerts, E. Kellen, J. V. van Meerbeeck, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer.

G. Giaccone, P. V. Van Schil, E. Smit, 2007, Journal of the National Cancer Institute.

Progression-free survival rate as primary end point for phase II cancer clinical trials: application to mesothelioma--The EORTC Lung Cancer Group.

M. van Glabbeke, J. V. van Meerbeeck, R. Sylvester, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Standard versus intensified chemotherapy with granulocyte colony-stimulating factor support in small-cell lung cancer: a prospective European Organization for Research and Treatment of Cancer-Lung Cancer Group Phase III Trial-08923.

G. Giaccone, P. Postmus, R. Dziadziuszko, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: an EORTC double-blind placebo-controlled phase III study.

G. Giaccone, P. Postmus, J. V. van Meerbeeck, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

Randomized comparison between antibiotics alone and antibiotics plus granulocyte-macrophage colony-stimulating factor (Escherichia coli-derived in cancer patients with fever and neutropenia.

E. Anaissie, H. Kantarjian, C. Legrand, 1996, American Journal of Medicine.

Induction chemotherapy (CT) in stage IIIA-N2 non-small cell lung cancer (NSCLC): An analysis of different regimens used in EORTC 08941

G. Giaccone, C. Legrand, T. Splinter, 2003 .

Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trial

B. Lambrecht, M. Buyse, C. Legrand, 2021, The Lancet Respiratory Medicine.

Single-dose montelukast or salmeterol as protection against exercise-induced bronchoconstriction.

C. Legrand, T. Loeys, T. Reiss, 2007, Chest.

Incidence and risk factors for adverse events during monitored anaesthesia care for gastrointestinal endoscopy in children: A prospective observational study

C. Legrand, J. Poelaert, Y. Vandenplas, 2019, European journal of anaesthesiology.

A randomized phase III study of cisplatin with or without raltitrexed in patients (pts) with malignant pleural mesothelioma (MPM): an intergroup study of the EORTC Lung Cancer Group and NCIC.

G. Giaccone, R. V. van Klaveren, E. van Marck, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pr5 A randomized trial of radical surgery (S) versus thoracicradiotherapy (TRT) in patients (pts) with stage IIIA-N2 non-small cell lung cancer (NSCLC) after response to induction chemotherapy (ICT) (EORTC 08941)

G. Giaccone, C. Legrand, T. Splinter, 2005 .

Hypofractionated external beam radiotherapy as retreatment for symptomatic non-small-cell lung carcinoma: an effective treatment?

J. V. van Meerbeeck, C. Legrand, S. Gans, 2004, International journal of radiation oncology, biology, physics.

Antifungal susceptibility of 44 clinical isolates of Fusarium species determined by using a broth microdilution method

E. Anaissie, C. Legrand, G. Bodey, 1989, Antimicrobial Agents and Chemotherapy.

Lessons to learn from EORTC study 08981: a feasibility study of induction chemoradiotherapy followed by surgical resection for stage IIIB non-small cell lung cancer.

R. V. van Klaveren, P. V. Van Schil, J. V. van Meerbeeck, 2007, Lung cancer.

Is a patient's self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975.

G. Giaccone, A. Bottomley, E. Smit, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Rapamycin improves TIE 2-mutated venous malformation in murine model and human subjects

E. Boscolo, M. Vikkula, C. Legrand, 2015 .

Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada.

G. Giaccone, R. V. van Klaveren, E. van Marck, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Lack of activity of amphotericin B in systemic murine fusarial infection.

E. Anaissie, C. Legrand, G. Bodey, 1992, The Journal of infectious diseases.

Bacteremia due to Achromobacter xylosoxidans in patients with cancer.

E. Anaissie, C. Legrand, 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Experimental fusarial hyalohyphomycosis in a murine model.

E. Anaissie, C. Legrand, G. Bodey, 1991, The Journal of infectious diseases.

Diagnostic performance of soluble mesothelin and megakaryocyte potentiating factor in mesothelioma.

K. Nackaerts, E. Kellen, J. V. van Meerbeeck, 2010, American journal of respiratory and critical care medicine.

Symptoms and patient-reported well-being: do they predict survival in malignant pleural mesothelioma? A prognostic factor analysis of EORTC-NCIC 08983: randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma.

A. Bottomley, J. V. van Meerbeeck, C. Legrand, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Do Intraoperative Analgesics Influence Breast Cancer Recurrence After Mastectomy? A Retrospective Analysis

J. Machiels, P. Forget, M. Berlière, 2010, Anesthesia and analgesia.

European organization for research and treatment of cancer (EORTC) 08957 phase II study of topotecan in combination with cisplatin as second-line treatment of refractory and sensitive small cell lung cancer.

G. Giaccone, E. Smit, C. Legrand, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Do intraoperative analgesics influence oncological outcomes after radical prostatectomy for prostate cancer?

B. Tombal, P. Forget, C. Legrand, 2011, European journal of anaesthesiology.

Three-arm randomized study of two cisplatin-based regimens and paclitaxel plus gemcitabine in advanced non-small-cell lung cancer: a phase III trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group--EORTC 08975.

G. Giaccone, E. Smit, F. Schramel, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Carboplatin and paclitaxol (Taxol) as an induction regimen for patients with biopsy-proven stage IIIA N2 non-small cell lung cancer. an EORTC phase II study (EORTC 08958).

G. Giaccone, E. Smit, M. Krzakowski, 2003, European Journal of Cancer.

Statistical methodology of phase III cancer clinical trials: advances and future perspectives.

M. van Glabbeke, L. Collette, T. Gorlia, 2002, European journal of cancer.

Overexpression of P70 S6 kinase protein is associated with increased risk of locoregional recurrence in node-negative premenopausal early breast cancer patients

M. J. van de Vijver, J. A. van der Hage, C. Legrand, 2004, British Journal of Cancer.

Rapamycin improves TIE2-mutated venous malformation in murine model and human subjects.

E. Boscolo, M. Vikkula, C. Legrand, 2015, The Journal of clinical investigation.

Treatment of operable breast cancer in the elderly: a randomised clinical trial EORTC 10851 comparing tamoxifen alone with modified radical mastectomy.

I. Fentiman, R. Paridaens, M. Christiaens, 2003, European journal of cancer.

Treatment of operable breast cancer in the elderly: a randomised clinical trial EORTC 10850 comparing modified radical mastectomy with tumorectomy plus tamoxifen.

I. Fentiman, P. Therasse, C. Legrand, 2003, European journal of cancer.

Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial.

E van der Schueren, H. Bartelink, I. Fentiman, 2001, Journal of the National Cancer Institute.

Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial.

Richard Sylvester, Harry Bartelink, H. Bartelink, 2000, Journal of the National Cancer Institute.

The effect of clinical covariates on the diagnostic and prognostic value of soluble mesothelin and megakaryocyte potentiating factor.

K. Nackaerts, E. Kellen, J. V. van Meerbeeck, 2012, Chest.

DNA alteration‐based classification of uveal melanoma gives better prognostic stratification than immune infiltration, which has a neutral effect in high‐risk group

M. Vikkula, C. Godfraind, P. Coulie, 2019, Cancer medicine.

Docetaxel and cisplatin as induction chemotherapy in patients with pathologically-proven stage IIIA N2 non-small cell lung cancer: a phase II study of the European organization for research and treatment of cancer (EORTC 08984).

G. Giaccone, J. V. van Meerbeeck, C. Legrand, 2006, European journal of cancer.

Randomized Controlled Trial of Resection Versus Radiotherapy After Induction Chemotherapy in Stage IIIA-N 2 Non – Small-Cell Lung Cancer

G. Giaccone, E. Smit, F. Schramel, 2007 .

A Randomized Phase II Study Comparing Two Schedules of the 21-Day Regimen of Gemcitabine and Carboplatin in Advanced Non-Small Cell Lung Cancer

R. Vernhout, R. V. van Klaveren, H. Hoogsteden, 2010, Oncology.

Phase III study of BEC2/BCG vaccination in limited disease small cell lung cancer (LD-SCLC) patients, following response to chemotherapy and thoracic irradiation (EORTC 08971, the SILVA study).

G. Giaccone, L. Thiberville, E. Felip, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

O-147 Surgery after induction chemotherapy: Morbidity and mortality in the first 100 patients of the surgery arm of EORTC 08941 trial

G. Giaccone, C. Legrand, T. Splinter, 2003 .

Diagnostic performance of soluble mesothelin and megakaryocyte potentiating factor in mesothelioma.

K. Nackaerts, E. Kellen, J. V. van Meerbeeck, 2010, American journal of respiratory and critical care medicine.